Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Capvaxive
Australian Public Assessment Report
Device/Product Name
Capvaxive
Active ingredients
Pneumococcal 21-valent Conjugate Vaccine
AusPAR Date
Published
Submission Number
PM-2023-05219-1-2
Submission Type
New biological entity
Decision
Approved